# US 2026/0241072 A1 · Method of repairing an annulus and collagen gel composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0241072 A1
- Document ID: US20260241072A1
- Status: Published application
- Kind: A1
- Application number: 19/644,249
- Filed: 2026-04-10
- Published: 2026-08-20
- Earliest claimed: 2013-12-03
- Assignees: Cornell University
- Applicants: Cornell University
- Inventors: Brandon BORDE; Peter GRUNERT; Roger HARTL; Lawrence BONASSAR
- Web page: https://patentgrep.com/patent/US20260241072A1

## CPC

- A61L 27/24: Collagen
- A61L 27/3658: {Intervertebral discs (mechanical aspects and structures of intervertebral discs A61F2/442)}
- A61L 27/38: {containing added animal cells (organs or tissue containing native cells A61L27/36)}
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/3817: {Cartilage-forming cells, e.g. pre-chondrocytes}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61F 2002/444: {for replacing the nucleus pulposus}
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2300/64: Animal cells
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/38: for reconstruction of the spine, vertebrae or intervertebral discs
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The present invention is directed to a method of repairing an annulus. This method involves providing a collagen gel composition that includes collagen gel and a cross-linking agent. The collagen gel composition is injected into, around, or near an annulus repair site under conditions to repair the annulus. The cross-linking agent is included with or added to the collagen gel in an amount sufficient to cause cross-linking of the collagen gel and enable integration of the collagen gel composition with tissue near where said collagen gel composition is injected. Also disclosed is collagen gel composition.

## Claims

### Claim 1

A method of repairing an annulus, said method comprising:
providing a collagen gel composition comprising:
collagen gel and
a cross-linking agent and
injecting the composition into, around, or near an annulus repair site under conditions to repair the annulus, wherein the cross-linking agent is included with or added to the collagen gel in an amount sufficient to cause cross-linking of the collagen gel and enable integration of the collagen gel composition with tissue near where said collagen gel composition is injected.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the collagen is type I collagen.

### Claim 3 (depends on 1)

The method according to claim 1 further comprising:
adding living cells to the collagen gel composition.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the living cells are selected from the group consisting of chondrocytes, fibroblasts, stem cells, and combinations thereof.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the collagen is included in the composition at a concentration of about 1-200 mg/ml.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the cross-linking agent is included in the composition at a concentration of up to about 7.5 mM.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the cross-linking agent is selected from the group consisting of riboflavin, rose bengal, ribose, decorin, carbodiimide, aldehydes, and combinations thereof.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the cross-linking agent is riboflavin.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the riboflavin is included in the composition at a concentration of 0.25 mM or 0.5 mM.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the collagen is included in the composition at a concentration of 15 mg/mL, the inducible cross-linking agent is riboflavin, and the riboflavin is included in the composition at a concentration of 0.25 mM or 0.5 mM.

### Claim 11 (depends on 1)

The method according to claim 1, wherein said injecting does not cause damage to surrounding tissue.

### Claim 12 (depends on 11)

The method according to claim 11, wherein said integration is with native tissue of the annulus.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the collagen gel composition is an injectable solution.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the collagen gel is acid extracted collagen gel.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the collagen gel is uncross-linked.

### Claim 16 (depends on 1)

The method according to claim 1, wherein the collagen gel has a viscosity to enable the collagen, when injected into an annular repair site, to conform to different shapes and sizes to match a tissue defect in the annular repair site.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the collagen is included in the composition at a concentration of 15-180 mg/ml.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the collagen gel composition further comprises:
a base.

### Claim 19 (depends on 18)

The method according to claim 18, wherein the base is NaOH.

### Claim 20 (depends on 1)

The method according to claim 1, wherein the cross-linking agent is inducible.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the cross-linking agent is photo-inducible.
